Drug Chatter -- Tracking biopharma stock chatter

Profile for Akebia Therapeutics, Inc. (AKBA)

« Back to company index

AKBA Chatter Timeline

Stock Ticker for AKBA

Most Active Tweeters for AKBA

UserTweets
@TickerReport 8
@confcalltran 5
@intercooleronli 5
@dakotafinancial 5
@emq_news 4

Recent Tweets for AKBA

dailymailtimes @dailymailtimes
Akebia Therapeutics, Inc. $AKBA Rating Lowered to Sell at BidaskClub https://t.co/vNoBqf7peK
July 19th 2017, 6:07pm
dakotafinancial @dakotafinancial
Akebia Therapeutics $AKBA Receives Media Impact Rating of 0.05 https://t.co/61Z2AuA5Lo
July 19th 2017, 3:07pm
TickerReport @TickerReport
Akebia Therapeutics $AKBA Receives Media Impact Rating of 0.05 https://t.co/uG8Vj9o6Gh
July 19th 2017, 1:07pm
TickerReport @TickerReport
Akebia Therapeutics $AKBA Receives Media Impact Rating of 0.05 https://t.co/dhBRrwPxDJ
July 19th 2017, 1:07pm
emq_news @emq_news
Akebia Therapeutics $AKBA Receives Media Impact Rating of 0.05 https://t.co/HaDkWOY2WL
July 19th 2017, 1:07pm
dailypoliticaln @dailypoliticaln
Akebia Therapeutics, Inc. $AKBA Downgraded by Zacks Investment Research to “Sell” https://t.co/ams9rz6zOC
July 19th 2017, 11:07am
midetimes @midetimes
Akebia Therapeutics, Inc. $AKBA Downgraded by Zacks Investment Research to “Sell” https://t.co/VF5PYOsChU
July 19th 2017, 10:07am
intercooleronli @intercooleronli
Zacks Investment Research Downgrades Akebia Therapeutics, Inc. $AKBA to Sell https://t.co/vDCT1ifMAT
July 18th 2017, 8:07pm
TickerReport @TickerReport
Akebia Therapeutics, Inc. $AKBA Rating Lowered to Sell at Zacks Investment Research https://t.co/wuV9tJdZn7
July 18th 2017, 7:07pm
TheMarketsDaily @TheMarketsDaily
Akebia Therapeutics, Inc. $AKBA Rating Lowered to Sell at Zacks Investment Research https://t.co/XThMKVzB6o
July 18th 2017, 7:07pm
TickerReport @TickerReport
Akebia Therapeutics, Inc. $AKBA Rating Lowered to Sell at Zacks Investment Research https://t.co/7stM2h7xt0
July 18th 2017, 7:07pm
emq_news @emq_news
Akebia Therapeutics, Inc. $AKBA Rating Lowered to Sell at Zacks Investment Research https://t.co/VuXzkiAk6X
July 18th 2017, 7:07pm
RatingsNetwork @RatingsNetwork
Akebia Therapeutics downgraded by Zacks Investment Research to sell. https://t.co/Nie7gLMDGe $AKBA #AKBA
July 18th 2017, 7:07pm
alex_fel @alex_fel
$AKBA its director invested 15M bucks on this play....?
July 18th 2017, 5:07am
realmaciej @realmaciej
RT @DrSManian: Huge insider bet - activist stake --> very bullish $AKBA ?? https://t.co/XeoNEZKpfn
July 17th 2017, 8:07pm
abbynac @abbynac
RT @insider_daily: On 2017-07-05, Satter Muneer A, Director of Akebia Therapeutics $AKBA, bought 1,034,482 shares at an average price of…
July 17th 2017, 8:07pm
DrSManian @DrSManian
Huge insider bet - activist stake --> very bullish $AKBA ?? https://t.co/XeoNEZKpfn
July 17th 2017, 8:07pm
TheMarketsDaily @TheMarketsDaily
Akebia Therapeutics, Inc. $AKBA Position Reduced by Trexquant Investment LP https://t.co/TQMngnci0e
July 14th 2017, 9:07pm
jfais20 @jfais20
Muneer A. Satter reports 6.48% stake in $AKBA
July 14th 2017, 8:07pm
SPNewsAnalysis @SPNewsAnalysis
Akebia Therapeutics $AKBA Receives Daily News Impact Score of 0.12 https://t.co/VJtIWQFXf8
July 14th 2017, 7:07pm
MaisaCorp @MaisaCorp
$AKBA Muneer Satter reports 6.48 pct stake in Akebia Therapeutics
July 14th 2017, 5:07pm
confcalltran @confcalltran
Muneer A. Satter just provided an update on activist position in Akebia Therapeutics, Inc. https://t.co/0hUH4NxV5A $AKBA
July 14th 2017, 5:07pm
fintel_io @fintel_io
Satter Muneer A has filed a new activist 13D, reporting 6.48% ownership in $AKBA - https://t.co/nezMS5rJSZ
July 14th 2017, 5:07pm
Pharmdca @Pharmdca
Several bios still lagging including $rvnc $akba
July 14th 2017, 11:07am
dakotafinancial @dakotafinancial
Akebia Therapeutics $AKBA Getting Somewhat Favorable Press Coverage, Accern Reports https://t.co/AuLL8OAA82
July 14th 2017, 10:07am
insider_daily @insider_daily
On 2017-07-05, Satter Muneer A, Director of Akebia Therapeutics $AKBA, bought 1,034,482 shares at an average price of $14.50 per share ...
July 14th 2017, 9:07am
insider_daily @insider_daily
... for a total of $15,000,000.00. He owns 3,037,042 shares of $AKBA Common Stock following this transaction. Reported on 2017-07-13.
July 14th 2017, 9:07am
dakotafinancial @dakotafinancial
Akebia Therapeutics, Inc. $AKBA Price Target Lowered to $24.00 at HC Wainwright https://t.co/eaKpmwZ0pu
July 14th 2017, 8:07am
WatchlistN @WatchlistN
Akebia Therapeutics $AKBA Getting Somewhat Favorable Press Coverage, Accern Reports https://t.co/ySZaPPQ8jI
July 14th 2017, 6:07am
ZolmaxNews @ZolmaxNews
Akebia Therapeutics, Inc. $AKBA Price Target Lowered to $24.00 at HC Wainwright https://t.co/RUYBw6vMI2
July 14th 2017, 2:07am
StockTipRobot @StockTipRobot
Talked to Warren Buffet's fax machine. It said bet the farm on Akebia Therapeutics $AKBA #NotRealStockAdvice
July 13th 2017, 4:07pm
bcasa003 @bcasa003
RT @zbiotech: $AKBA COB added 1M to original 2M share position at ~13% discount to 2+ yr high...now at 6.5% and #4 holder, i'd call that so…
July 13th 2017, 1:07pm
emq_news @emq_news
Akebia Therapeutics, Inc. $AKBA PT Lowered to $24.00 at HC Wainwright https://t.co/MctcB3XUSf
July 13th 2017, 11:07am
TickerReport @TickerReport
Akebia Therapeutics, Inc. $AKBA PT Lowered to $24.00 at HC Wainwright https://t.co/LU57CyV7fN
July 13th 2017, 11:07am
TickerReport @TickerReport
Akebia Therapeutics, Inc. $AKBA PT Lowered to $24.00 at HC Wainwright https://t.co/GdPxl4NrUv
July 13th 2017, 11:07am
IRAMarketReport @IRAMarketReport
Muneer A. Satter Buys 1,034,482 Shares of Akebia Therapeutics, Inc. $AKBA Stock https://t.co/h75Qch5JKa
July 13th 2017, 10:07am
chaffeybreeze @chaffeybreeze
Muneer A. Satter Buys 1,034,482 Shares of Akebia Therapeutics, Inc. $AKBA Stock https://t.co/lfx1fEYzZs
July 13th 2017, 10:07am
TheMarketsDaily @TheMarketsDaily
Akebia Therapeutics, Inc. $AKBA Director Muneer A. Satter Buys 1,034,482 Shares of Stock https://t.co/iA3jhEYqXS
July 12th 2017, 4:07pm
ZolmaxNews @ZolmaxNews
Akebia Therapeutics, Inc. $AKBA Director Muneer A. Satter Buys 1,034,482 Shares of Stock https://t.co/YkGiVT4EOi
July 12th 2017, 3:07pm
insider_daily @insider_daily
On 2017-07-05, Satter Muneer A, Director of Akebia Therapeutics $AKBA, bought 1,034,482 shares at an average price of $14.50 per share ...
July 12th 2017, 1:07pm
insider_daily @insider_daily
... for a total of $15,000,000.00. He owns 3,037,042 shares of $AKBA Common Stock following this transaction. Reported on 2017-07-12.
July 12th 2017, 1:07pm
zbiotech @zbiotech
$AKBA COB added 1M to original 2M share position at ~13% discount to 2+ yr high...now at 6.5% and #4 holder, i'd call that some confidence
July 12th 2017, 11:07am
midetimes @midetimes
Akebia Therapeutics, Inc. $AKBA Price Target Cut to $24.00 https://t.co/jzSaoWks0e
July 12th 2017, 7:07am
ChartEyez @ChartEyez
$AKBA Director Insider buy from the recent offering: https://t.co/b3u64mfpEb
July 12th 2017, 1:07am
IRAMarketReport @IRAMarketReport
Akebia Therapeutics, Inc. $AKBA Price Target Lowered to $24.00 at HC Wainwright https://t.co/s5BWq8hXmk
July 11th 2017, 5:07pm
WatchlistN @WatchlistN
Akebia Therapeutics, Inc. $AKBA Price Target Lowered to $24.00 at HC Wainwright https://t.co/vsO8cAT5Wz
July 11th 2017, 5:07pm
chaffeybreeze @chaffeybreeze
Akebia Therapeutics, Inc. $AKBA Price Target Lowered to $24.00 at HC Wainwright https://t.co/cTsftF7Sjy
July 11th 2017, 5:07pm
InsiderAlertsIA @InsiderAlertsIA
$AKBA: New Insider Filing on Director MUNEER A SATTER: https://t.co/QB98cD1yhA
July 11th 2017, 4:07pm
BiotechSage @BiotechSage
$AKBA Satter Muneer acquired 1.03M shares on the company's recent financing https://t.co/3ozVsUGHY6
July 11th 2017, 4:07pm
confcalltran @confcalltran
Akebia Therapeutics, Inc. director just picked up 1,034,482 shares https://t.co/ecrhfh15vW $AKBA
July 11th 2017, 4:07pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.